ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
Closed while relocating
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
The MCS rally: how’s this for fast action?
Wednesday 10 October 2007
Only one good politician attended the MCS rally on 8 October. But Sandra Kanck MLC (pictured) was enough.
Thanks Sandra, thanks Lyn.
No thanks to the Commonwealth Office of Chemical Safety for its lack of action on MCS issues.
From Cathi Tucker, Australian Democrats (SA) Research-Liaison Officer
Below is a Question on Notice placed by Senator Lyn Allison (Democrats, Victoria – Australia). It was good to see some familiar faces down at the MCS rally in Adelaide on Monday, thanks to the SA Taskforce on MCS for organising.
Cheers all, Cathi.
Question on Notice
Senator Allison asks the Minister representing the Minister for Health and Ageing:
1. Has the National Industrial Chemicals Notification and Assessment Scheme Community Engagement Forum undertaken to conduct a community consultation on Multiple Chemical Sensitivity? If so, when will this consultation be conducted?
2. Given the complex disability access issues for people with Multiple Chemical Sensitivity, how will the National Industrial Chemicals Notification and Assessment Scheme Community Engagement Forum ensure that people with Multiple Chemical Sensitivity are adequately consulted?
3. When will the Office of Chemical Safety publicly release the results of the Multiple Chemical Sensitivity clinical review conducted in Sydney?
Senator Lyn Allison